Relationship between Atherosclerosis and Cancer: An observational outcome study

Adams Ansgar, Bojar Waldemar, Romanens Michel
{"title":"Relationship between Atherosclerosis and Cancer: An observational outcome study","authors":"Adams Ansgar, Bojar Waldemar, Romanens Michel","doi":"10.17352/2455-8702.000134","DOIUrl":null,"url":null,"abstract":"Background and aims: It was investigated whether there is a relationship between advanced atherosclerosis of the carotid artery and cancer. Method: The carotid Total Plaque Area (TPA), the maximum plaque thickness, and the cardiovascular risk based on Framingham calculator using body-mass-index were determined in healthy subjects using ultrasound. We compared the outcome in subjects with advanced atherosclerosis of the carotid artery (type III-IV b finding) with and without statin treatment. The follow-up was collected as part of occupational health check-ups. Result: In 4207 healthy men aged 35-65 years (50±8 years) we found 578 subjects with advanced atherosclerosis of the carotid artery (type III-IV b finding). A follow-up was available for 566 (97.9%) subjects. The average follow-up time was 48 months (range 0 to 139 months). Ten subjects were excluded because of missing data on treatment. A total number of 230 subjects was treated with a statin, 326 received no statin. Within the group of these subjects (54±6 years), 33 men died (15 cancer, 4 strokes, 11 heart attacks, 1 COPD, 1 sepsis, 1 cirrhosis of the liver). In the group with CVD death, two subjects were treated with a statin, 13 were untreated. In the group with cancer death, two subjects were treated with a statin, 13 were untreated. The death rate because of cancer and CVD was 1.7% for the treated subjects and 8.0% for the untreated subjects. In the group with low risk (n= 1890), six men died (2 traffic accidents, 1aneurysm bleeding, 2 cancer, 1 unclear, a follow-up examination has been completed for 43.9% (n= 830) of the subjects, mean follow-up time of 65 months (0-137 months). One man died (Parkinson) within the group with intermediate risk. In this group (n= 482) a follow-up examination has been completed for 55% (n= 265) with a mean follow-up time of 55 months (total range: 0-130 months). In the reference group (no atherosclerosis; n= 1257) follow-up has been completed in 38.3% (n= 482) with a mean follow-up time of 60 (0-145) months and nobody died. In 3203 healthy women aged 35-65 years nobody died of cancer. Conclusion: The development of cancer in men with advanced atherosclerosis of the carotid artery appears to be noticeable. The question of whether there is a causal relationship requires further investigations.","PeriodicalId":376164,"journal":{"name":"Imaging Journal of Clinical and Medical Sciences","volume":"28 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Imaging Journal of Clinical and Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17352/2455-8702.000134","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aims: It was investigated whether there is a relationship between advanced atherosclerosis of the carotid artery and cancer. Method: The carotid Total Plaque Area (TPA), the maximum plaque thickness, and the cardiovascular risk based on Framingham calculator using body-mass-index were determined in healthy subjects using ultrasound. We compared the outcome in subjects with advanced atherosclerosis of the carotid artery (type III-IV b finding) with and without statin treatment. The follow-up was collected as part of occupational health check-ups. Result: In 4207 healthy men aged 35-65 years (50±8 years) we found 578 subjects with advanced atherosclerosis of the carotid artery (type III-IV b finding). A follow-up was available for 566 (97.9%) subjects. The average follow-up time was 48 months (range 0 to 139 months). Ten subjects were excluded because of missing data on treatment. A total number of 230 subjects was treated with a statin, 326 received no statin. Within the group of these subjects (54±6 years), 33 men died (15 cancer, 4 strokes, 11 heart attacks, 1 COPD, 1 sepsis, 1 cirrhosis of the liver). In the group with CVD death, two subjects were treated with a statin, 13 were untreated. In the group with cancer death, two subjects were treated with a statin, 13 were untreated. The death rate because of cancer and CVD was 1.7% for the treated subjects and 8.0% for the untreated subjects. In the group with low risk (n= 1890), six men died (2 traffic accidents, 1aneurysm bleeding, 2 cancer, 1 unclear, a follow-up examination has been completed for 43.9% (n= 830) of the subjects, mean follow-up time of 65 months (0-137 months). One man died (Parkinson) within the group with intermediate risk. In this group (n= 482) a follow-up examination has been completed for 55% (n= 265) with a mean follow-up time of 55 months (total range: 0-130 months). In the reference group (no atherosclerosis; n= 1257) follow-up has been completed in 38.3% (n= 482) with a mean follow-up time of 60 (0-145) months and nobody died. In 3203 healthy women aged 35-65 years nobody died of cancer. Conclusion: The development of cancer in men with advanced atherosclerosis of the carotid artery appears to be noticeable. The question of whether there is a causal relationship requires further investigations.
动脉粥样硬化与癌症的关系:一项观察性结果研究
背景与目的:探讨颈动脉晚期动脉粥样硬化与癌症的关系。方法:采用超声测量健康人颈动脉总斑块面积(TPA)、最大斑块厚度及基于Framingham计算器的体质量指数心血管风险。我们比较了接受和不接受他汀类药物治疗的晚期颈动脉粥样硬化患者(III-IV型)的结果。随访是作为职业健康检查的一部分收集的。结果:在4207名年龄在35-65岁(50±8岁)的健康男性中,我们发现578名受试者患有晚期颈动脉粥样硬化(III-IV型b)。对566名(97.9%)受试者进行了随访。平均随访时间48个月(0 ~ 139个月)。10名受试者因缺少治疗数据而被排除。共有230名受试者接受他汀类药物治疗,326名受试者未接受他汀类药物治疗。在这组受试者(54±6年)中,33名男性死亡(15例癌症,4例中风,11例心脏病发作,1例慢性阻塞性肺病,1例败血症,1例肝硬化)。在CVD死亡组中,2名受试者接受他汀类药物治疗,13名未接受治疗。在癌症死亡组中,两名受试者接受了他汀类药物治疗,13名未接受治疗。治疗组因癌症和心血管疾病的死亡率为1.7%,未治疗组为8.0%。低危组(n= 1890)死亡6例(交通事故2例,动脉瘤出血1例,癌症2例,不明原因1例),完成随访检查的43.9% (n= 830),平均随访时间65个月(0 ~ 137个月)。中度风险组中有1人死亡(帕金森)。本组(n= 482)有55% (n= 265)完成了随访检查,平均随访时间为55个月(总范围:0-130个月)。参照组(无动脉粥样硬化;随访率为38.3% (N = 482),随访时间为60(0 ~ 145)个月,无死亡病例。在3203名35-65岁的健康妇女中,没有人死于癌症。结论:男性颈动脉晚期动脉粥样硬化患者的癌症发展趋势明显。是否存在因果关系的问题需要进一步调查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信